De Marco, G., Helliwell, P., McGonagle, D., Emery, P., Coates, L., Hensor, E., & Marzo-Ortega, H. (2017). The GOLMePsA study protocol: An investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes. BioMed Central.
Chicagoスタイル(17版)引用形式De Marco, G., P. Helliwell, D. McGonagle, P. Emery, L. Coates, E. Hensor, , H. Marzo-Ortega. The GOLMePsA Study Protocol: An Investigator-initiated, Double-blind, Parallel-group, Randomised, Controlled Trial of GOLimumab and Methotrexate Versus Methotrexate in Early Diagnosed Psoriatic Arthritis Using Clinical and Whole Body MRI Outcomes. BioMed Central, 2017.
MLA(9版)引用形式De Marco, G., et al. The GOLMePsA Study Protocol: An Investigator-initiated, Double-blind, Parallel-group, Randomised, Controlled Trial of GOLimumab and Methotrexate Versus Methotrexate in Early Diagnosed Psoriatic Arthritis Using Clinical and Whole Body MRI Outcomes. BioMed Central, 2017.